Professional Summary
Professional Overview
Katie Chapman is an accomplished Head of Discovery Biology with a proven track record of driving innovation and delivering impactful results in the biotechnology industry. With extensive expertise in assay development, target validation, and project leadership, she is a respected leader in the field of drug discovery.
Experience Summary
Current Role
As the Head of Discovery Biology at Tessellate BIO, Katie is responsible for leading a team of talented scientists in the discovery and development of novel therapeutic candidates. In this role, she has been instrumental in streamlining the company's drug discovery pipeline, implementing cutting-edge technologies, and fostering collaborative partnerships to accelerate the translation of innovative ideas into viable drug candidates.
Career Progression
Prior to joining Tessellate BIO, Katie held several notable positions, including Biology Discovery Director at a VC-funded biotech company, Associate Principal Scientist at MSD, and Group Leader of Assay Biology at Domainex. Throughout her career, she has demonstrated exceptional leadership skills, a keen eye for scientific innovation, and a commitment to driving progress in the biotechnology field.
As the Biology Discovery Director, Katie led a multidisciplinary team in the successful identification and validation of promising drug targets, culminating in the advancement of several candidates into preclinical development. At MSD, she played a pivotal role in the development and optimization of high-throughput screening assays, contributing to the advancement of the company's drug discovery pipeline.
During her tenure at Domainex, Katie rose through the ranks, starting as a Senior Assay Scientist and eventually becoming the Group Leader of Assay Biology. In this role, she spearheaded the establishment of robust and reliable assay platforms, which enabled the company to accelerate the discovery of novel lead compounds.
Academic Background
Katie holds a Ph.D. in Biochemistry and Molecular Biology from Imperial College London, where she also served as a Senior Scientist and an Honorary Research Fellow, contributing to cutting-edge research and advancing the field of assay development.
Areas of Expertise
- Assay development and optimization
- Target validation and drug discovery
- High-throughput screening and lead identification
- Multidisciplinary team leadership and collaboration
- Strategic planning and project management
- Translating scientific innovations into viable drug candidates
Professional Impact
Throughout her career, Katie has consistently demonstrated her ability to drive scientific progress and deliver tangible results. Her contributions have been instrumental in advancing the discovery of several drug candidates, with a particular focus on complex disease targets and unmet medical needs. Katie's industry-leading expertise, combined with her exceptional leadership skills, make her a valuable asset in the biotechnology field.
Conclusion
Katie Chapman is a dynamic and visionary leader in the field of discovery biology. With her extensive experience, deep scientific expertise, and a proven track record of success, she is poised to continue making significant contributions to the development of innovative therapeutic solutions that address pressing healthcare challenges.
